‘We need vaccines with longer duration and greater breadth of protection,’ said Dr. David Kessler, chief science officer for the White House’s COVID-19 response team.
: Moderna and Pfizer to start clinical trials for COVID-19 boosters that target BA.5 ‘in the near future’
Advertisements